We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

44 hedge funds and large institutions have $44.5M invested in InVivo Therapeutics Holdings Corp in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

217% more call options, than puts

Call options by funds: $1.57M | Put options by funds: $494K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 46 → 44 (-2)

11% less capital invested

Capital invested by funds: $49.8M → $44.5M (-$5.39M)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

Holders
44
Holders Change
-2
Holders Change %
-4.35%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
12
Reduced
3
Closed
8
Calls
$1.57M
Puts
$494K
Net Calls
+$1.07M
Net Calls Change
-$2.15M

Top Buyers

Rank Fund Capital Flow
1
BFM
Boston Financial Management
Massachusetts
+$470K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$470K
3
ICM
IMS Capital Management
Oregon
+$353K
4
Northern Trust
Northern Trust
Illinois
+$353K
5
BIT
BlackRock Institutional Trust
California
+$235K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$353K
2
Deutsche Bank
Deutsche Bank
Germany
-$235K
3
Renaissance Technologies
Renaissance Technologies
New York
-$221K
4
SG Americas Securities
SG Americas Securities
New York
-$143K
5
AIM
Alambic Investment Management
California
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.05M +$470K +4 +8%
WF
2
Welch & Forbes
Massachusetts
$5.66M +$235K +2 +4%
BFA
3
BlackRock Fund Advisors
California
$4.79M – – –
BIT
4
BlackRock Institutional Trust
California
$4.43M +$235K +2 +5%
SM
5
Sabby Management
Florida
$3.35M +$235K +2 +7%
State Street
6
State Street
Massachusetts
$2.37M +$118K +1 +5%
BBA
7
Baker Bros. Advisors
New York
$2.31M – – –
Northern Trust
8
Northern Trust
Illinois
$1.98M +$353K +3 +20%
Goldman Sachs
9
Goldman Sachs
New York
$1.93M -$118K -1 -5%
ICM
10
IMS Capital Management
Oregon
$1.87M +$353K +3 +21%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.16M – – –
Morgan Stanley
12
Morgan Stanley
New York
$849K – – –
BIM
13
BlackRock Investment Management
Delaware
$747K – – –
Bank of New York Mellon
14
Bank of New York Mellon
New York
$697K – – –
TCIM
15
TIAA CREF Investment Management
New York
$590K – – –
BCM
16
Bridgeway Capital Management
Texas
$524K – – –
BFM
17
Boston Financial Management
Massachusetts
$429K +$470K +4 New
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$390K – – –
Charles Schwab
19
Charles Schwab
California
$338K +$118K +1 +50%
UBS Group
20
UBS Group
Switzerland
$323K +$118K +1 +50%
TA
21
Teachers Advisors
New York
$258K – – –
CS
22
Credit Suisse
Switzerland
$254K +$118K +1 +100%
Stifel Financial
23
Stifel Financial
Missouri
$241K +$235K +2 New
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$223K +$118K +1 +100%
LPL Financial
25
LPL Financial
California
$186K -$118K -1 -33%
1
2 3

NVIV Hedge Fund Activity: Q2 2016 in Review

44 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q2 2016, worth a combined $44.5M — down 11% from $49.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NVIV and 7 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 12 added.

The largest buyer was Boston Financial Management, opening a new position worth an estimated $470K. The largest seller was Susquehanna International Group, cutting an estimated $353K.

  • 44 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q2 2016, down from 46 in Q1 2016.
  • Funds reported $44.5M of InVivo Therapeutics Holdings Corp stock for Q2 2016, down 11% quarter-over-quarter.
  • 7 funds opened new InVivo Therapeutics Holdings Corp positions in Q2 2016 and 8 closed out, a net change of -1 holder.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q2 2016 was Boston Financial Management, an estimated $470K added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q2 2016 was Susquehanna International Group, an estimated $353K sold.

Based on aggregated 13F filings for Q2 2016.